Home > Healthcare > Medical Devices > Medical Supplies > MRI Contrast Media Market

MRI Contrast Media Market Share

Report ID: GMI7600
Published Date: Dec 2023
Report Format: PDF

Download Free Sample

MRI Contrast Media Market Share

The pharmaceutical and biotechnology companies are actively operating in the market, leveraging their research capabilities and global presence. Strategic collaborations, product innovations, and regulatory compliance further strengthen their positions. The market is characterized by ongoing technological advancements and a focus on developing safer and more effective contrast agents, intensifying the competitive dynamics in this vital healthcare segment.

MRI Contrast Media Market Company

The prominent players operating in the MRI contrast media industry is as mentioned below:

Bayer HealthCare LLC
Guerbet LLC
GE HealthCare
Lantheus Medical Imaging, Inc.
B. Chemicals and Pharmaceuticals Ltd.
Bracco
BioPAL, Inc.
Vitalquan, LLC
Fresenius Kabi
Polarean.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The hospitals segment is anticipated to record over 4.5% CAGR from 2023 to 2032 as these are primary facilities for patients undergoing major diagnostic tests, making MRI contrast media the focal point.

The extracellular contrast agents segment is expected to reach USD 1.9 billion by 2032 due to their efficacy in enhancing image contrast.

Bayer HealthCare LLC, Guerbet LLC, GE HealthCare, Lantheus Medical Imaging, Inc., B. Chemicals and Pharmaceuticals Ltd., Bracco, BioPAL, Inc., Vitalquan, LLC, Fresenius Kabi, and Polarean.